Defects in the prostaglandin system - What is known?

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 71, Issue 5, 2004, Pages 347-350

  Reiter, Rosemarie A ^a   Peskar, Bernhard A ^b   Sinzinger, Helmut ^c,d  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

^c DANUBE UNIVERSITY KREMS   (Austria)

^d Wilhelm Auerswald Atherosclerosis Research Group   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN;

ALLELE; ARTICLE; BIOSYNTHESIS; ENZYME DEFECT; ENZYME SYNTHESIS; GENE EXPRESSION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; PROSTAGLANDIN SYNTHESIS; RISK ASSESSMENT; RISK FACTOR; THROMBOPHILIA; VASCULAR DISEASE;

ANIMALS; ARACHIDONIC ACID; BLOOD PLATELETS; EPOPROSTENOL; HEMORRHAGE; HUMANS; LIPOXYGENASE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; THROMBOSIS; THROMBOXANE-A SYNTHASE;

EID: 4544290660     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2004.07.003     Document Type: Article

References (31)

1. H. Kritz, J. Pidlich, J. O'Grady, and H. Sinzinger Is a(n inborn) deficiency of prostacyclin synthesis stimulating plasma factor associated with increased lipoprotein(a)? Prostaglandins Leucot. Essent. Fatty Acids 55 1996 363 372
2. M. Okuma, and H. Uchino Platelet lipooxygenase deficiency New Engl. J. Med. 297 1977 1351 1352
3. M. Okuma, and H. Uchino Altered arachidonate metabolism by platelets in patients with myeloproliferative disorders Blood 54 1979 1258 1271
4. N. Matijevic-Aleksic, P. McPhedran, and K.K. Wu Bleeding disorder due to platelet prostaglandin H synthase-1 (PGHS-1) deficiency Br. J. Haematol. 92 1996 212 217
5. H. Sinzinger, J. Kaliman, and J. O'Grady Platelet lipooxygenase defect (Wien-Penzing Defect) in two patients with myocardial infarction Am. J. Haematol. 36 1991 202 205
6. I. Virgolini, B.A. Peskar, J. O'Grady, and H. Sinzinger Defects in the prostaglandin system - prevalence, heredity and vascular risk analysis Prostaglandins Leucot. Essent. Fatty Acids 40 1990 227 237
7. S. Moncada, E.A. Higgs, and J.R. Vane Human arterial and venous tissues generate prostacyclin. A potent inhibitor of platelet aggregation Lancet 1 1976 18 20
8. O. Burghuber, C. Punzengruber, H. Sinzinger, P. Haber, and K. Silberbauer Platelet sensitivity to prostacyclin in smokers and non-smokers Chest 90 1986 34 38
9. 2 on platelet aggregation and adenylate cyclase activity in human type IIa hypercholesterolemia Biochem. Pharmacol. 32 1983 1989 1993
10. J.A. Colwell, P.V. Halushka, K. Sarji, J. Levine, J. Sagel, and R.M. Nair Altered platelet function in diabetes mellitus Diabetes 25 1976 826 831
11. G. Steurer, J. Kaliman, D. Gludovacz, and H. Sinzinger Successful therapy of the prostaglandin defect "Wien Hietzing" Prostaglandins 39 1990 693 703
12. Y. Tsujita, M. Kinoshita, T. Tanabe, and N. Iwai Role of a genetic variation in the promoter of human thromboxane synthase gene in myocardial infarction Atherosclerosis 153 2000 261 262
13. 2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease Circulation 88 1993 2117 2122
14. R.M. Tuder, C.D. Cool, and M.W. Geraci Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension Am. J. Respir. Crit. Care Med. 159 1999 1925 1932
15. K. Schrör, and E.F. Smith Dictionary of Prostaglandins 1990 Medikon Verlag München
16. 2 receptor Nat. Med. 5 1999 217 220
17. 2 receptor impairs osteoclastogenesis in vitro Endocrinology 141 2000 2054 2061
18. S. Narumiya, Y. Sugimoto, and F. Ushikubi Prostanoid receptors structures, properties, and functions Physiol. Rev. 79 1999 1193 1226
19. F. Ushikubi, Y. Sugimoto, A. Ichikawa, and S. Narumiya Roles of prostanoids from studies using mice lacking specific prostanoid receptors Jpn. J. Pharmacol. 83 2000 279 285
20. H. Ma, A. Hara, and C.Y. Xiao Increased bleeding tendency and decreased susceptibility to thromboembolism in mice lacking the prostaglandin E receptor subtype EP(3) Circulation 104 2001 1176 1180
21. D.W. Thomas, R.B. Mannon, and P.J. Mannon Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2 J. Clin. Invest. 102 1998 1994 2001
22. 2 in cardiac ischemia-reperfusion injury a study using mice lacking their respective receptors Circulation 104 2001 2210 2215
23. D. Pratico, T. Cyrus, H. Li, and G.A. FitzGerald Endogenous biosynthesis of thromboxane and prostacyclin in 2 distinct murine models of atherosclerosis Blood 96 2000 3823 3826
24. Y. Sugimoto, S. Narumiya, and A. Ichikawa Distribution and function of prostanoid receptors studies from knockout mice Progr. Lipid Res. 39 2000 289 314
25. H. Lim, B.C. Paria, and S.K. Das Multiple female reproductive failures in cyclooxygenase 2-deficient mice Cell 91 1997 197 208
26. R. Langenbach, S.G. Morham, and H.F. Tiano Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration Cell 83 1995 483 492
27. 2 and interleukin-1beta Endocrinology 140 1999 2685 2695
28. H. Hizaki, E. Segi, and Y. Sugimoto Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP2 Proc. Natl. Acad. Sci. 96 1999 10501 10506
29. J.E. Dinchuk, B.D. Car, and R.J. Focht Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II Nature 378 1995 4306 4408
30. V.F. Norwood, S.C. Morham, and O. Smithies Postnatal development and progression of renal dysplasia in cyclooxygenase-2 null mice Kidney Int. 58 2000 2291 2300
31. 2 levels in rat embryos exposed to a diabetic environment Diabetes 48 1999 813 820